Elicera Therapeutics AB (publ) (ELIC.ST)
SEK 1.71
(-0.29%)
SEK 1.71
(-0.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 11.23 Million | 1.28 Million | 587.00 | - | - | - |
| Cost of Revenue | 11.77 Thousand | 11.77 Thousand | 11.77 Thousand | 11.77 Thousand | - | - |
| Gross Profit | 11.21 Million | 1.26 Million | -11.18 Thousand | -11.77 Thousand | - | - |
| Operating Expenses | 28.32 Million | 19.36 Million | 13.11 Million | 2.82 Million | 194.25 Thousand | 3525.00 |
| Selling, General and Administrative Expenses | 28.31 Million | 20.63 Million | 8.95 Million | 1.84 Million | 194.25 Thousand | 3525.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 11.77 Thousand | 19.36 Million | 4.16 Million | 985.95 Thousand | - | - |
| Cost and Expenses | 28.32 Million | 19.36 Million | 13.11 Million | 2.82 Million | 194.25 Thousand | 3525.00 |
| Operating Income | -17.09 Million | -19.36 Million | -13.11 Million | -2.82 Million | -194.25 Thousand | -3520.00 |
| Interest Expense | - | 129.34 Thousand | 1075.00 | - | - | - |
| Income Tax Expense | - | 75.88 Thousand | 1075.00 | -5418.00 | -3187.00 | -3525.00 |
| Earnings before Tax | -16.39 Million | -19.43 Million | -13.12 Million | -2.82 Million | -191.06 Thousand | -3525.00 |
| Net Income | -16.39 Million | -19.51 Million | -13.12 Million | -2.81 Million | -187.87 Thousand | -3525.00 |
| Earnings Per Share Basic | -0.83 | -0.99 | -0.82 | -0.23 | -0.02 | -0.00 |
| Earnings Per Share Diluted | -0.83 | -0.99 | -0.82 | -0.23 | -0.02 | -0.00 |
| Weighted Average Shares Outstanding | 19.78 Million | 19.78 Million | 15.93 Million | 12.03 Million | 12.03 Million | 12.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.78 Million | 19.78 Million | 15.93 Million | 12.03 Million | 12.03 Million | 12.03 Million |
| Gross Margin | 1.00 | 0.99 | -19.06 | - | - | - |
| EBIT Margin | -1.52 | -15.07 | -22.32 Thousand | - | - | - |
| Profit Margin | -1.46 | -15.24 | -22.35 Thousand | - | - | - |
| EBITDA | -17.08 Million | -19.42 Million | -13.1 Million | -2.81 Million | 3190.00 | - |
| Earnings Before Tax Margin | -1.52 | -15.13 | -22.34 Thousand | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 988.7 Thousand | 3.03 Million | 27.69 Thousand | 11.23 Million | 8.01 Million | 1.77 Million |
| Cost of Revenue | 2946.00 | 2946.00 | 2938.00 | 11.77 Thousand | 2946.00 | 2946.00 |
| Gross Profit | 985.75 Thousand | 3.03 Million | 24.75 Thousand | 11.21 Million | 8.01 Million | 1.76 Million |
| Operating Expenses | 6.82 Million | 5.43 Million | 5.24 Million | 28.31 Million | 5.14 Million | 4.46 Million |
| Selling, General and Administrative Expenses | 6.82 Million | 8.46 Million | 5.23 Million | - | 13.16 Million | 6.23 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2946.00 | - | -2940.00 | -11.78 Thousand | - | - |
| Cost and Expenses | 6.83 Million | 5.43 Million | 5.24 Million | 28.32 Million | 5.14 Million | 4.46 Million |
| Operating Income | -6.83 Million | -5.43 Million | -5.24 Million | -28.32 Million | -5.14 Million | -4.46 Million |
| Interest Expense | 4467.00 | 31.52 Thousand | 2452.00 | - | 61.93 Thousand | 11.61 Thousand |
| Income Tax Expense | 4.00 | 95.27 Thousand | 2.00 | 4.00 | 164.79 Thousand | 142.04 Thousand |
| Earnings before Tax | -5.62 Million | -5.36 Million | -4.74 Million | -16.39 Million | -5.04 Million | -4.33 Million |
| Net Income | -5.62 Million | -5.36 Million | -4.74 Million | -16.39 Million | -5.04 Million | -4.33 Million |
| Earnings Per Share Basic | -0.16 | -0.26 | -0.24 | - | -0.26 | -0.22 |
| Earnings Per Share Diluted | -0.16 | -0.25 | -0.24 | - | -0.26 | -0.22 |
| Weighted Average Shares Outstanding | 35.09 Million | 20.79 Million | 19.78 Million | 19.78 Million | 19.78 Million | 19.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.09 Million | 21.3 Million | 19.78 Million | 19.78 Million | 19.78 Million | 19.78 Million |
| Gross Margin | 1.00 | 1.00 | 0.89 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -6.91 | -1.76 | -189.19 | - | -0.62 | -2.44 |
| Profit Margin | -5.69 | -1.77 | -171.49 | -1.46 | -0.63 | -2.45 |
| EBITDA | -6.82 Million | -5.33 Million | -5.23 Million | - | -4.98 Million | -4.32 Million |
| Earnings Before Tax Margin | -6.91 | -1.79 | -189.30 | -2.52 | -0.64 | -2.52 |
ITVI
MXC
TRIVENI
GMED
UKW
BHP